For a patient on insulin glargine (Lantus) 18 units with an insulin‑sensitivity factor of 25 mg/dL per unit and an insulin‑to‑carbohydrate ratio of 10 g per unit, who has blood glucose readings of 234 mg/dL at 5 PM after eating 66 g of carbohydrate, 240 mg/dL at 9 PM, and 201 mg/dL at 2 AM, what should the insulin‑sensitivity factor, insulin‑to‑carbohydrate ratio, and basal Lantus dose be adjusted to?

Insulin Dose Adjustment Analysis

Based on these blood glucose readings showing persistent hyperglycemia (234→240→201 mg/dL) despite adequate carbohydrate coverage, you need to increase the Lantus basal dose by 2-4 units and reassess the insulin-to-carbohydrate ratio, as the current regimen is failing to achieve glycemic targets.

Current Situation Assessment

Your patient's glucose pattern reveals:

• Pre-dinner BG: 234 mg/dL (target <130 mg/dL)
• Bedtime BG: 240 mg/dL (minimal change after meal)
• Overnight BG: 201 mg/dL (still elevated)

The meal bolus calculation was: 66g CHO ÷ 10 (ICR) = 6.6 units, plus correction dose using ISF 25.

Basal Insulin (Lantus) Adjustment

Increase Lantus from 18 to 20-22 units 1, 2. The persistent overnight hyperglycemia (201 mg/dL at 2 AM) indicates inadequate basal coverage. The ADA 2025 guidelines recommend increasing basal insulin by 2 units every 3 days when fasting/basal glucose remains above target without hypoglycemia 1.

The fact that BG remained elevated throughout the night (234→240→201) despite no additional food intake strongly suggests basal insulin insufficiency rather than bolus miscalculation.

Insulin Sensitivity Factor (ISF) Evaluation

Keep ISF at 25 mg/dL per unit for now, but monitor closely. The "1800 rule" (1800 ÷ total daily dose) can validate this. If total daily insulin is approximately 30-35 units (18 basal + 12-17 bolus), the calculated ISF would be 51-60, suggesting your current ISF of 25 may actually be too aggressive. However, the persistent hyperglycemia suggests insulin resistance, so maintain current ISF until basal is optimized.

Insulin-to-Carbohydrate Ratio (ICR) Assessment

Consider tightening ICR from 1:10 to 1:8 or 1:9 after basal optimization. The minimal glucose change from 5 PM to 9 PM (234→240) after 66g CHO and appropriate bolus suggests the ICR may be inadequate. Research indicates typical ICR in type 1 diabetes averages around 1:9.3 3, and the "500 rule" (500 ÷ total daily dose) would suggest an ICR of 14-17 with current dosing—your 1:10 ratio appears reasonable but may need tightening.

Critical caveat: Do NOT adjust ICR until basal insulin is optimized. The elevated pre-meal glucose (234 mg/dL) makes it impossible to accurately assess prandial insulin effectiveness 1.

Recommended Action Algorithm

1. Immediate: Increase Lantus to 20 units (2-unit increment) 1, 2
2. Monitor for 3 days: Check fasting/pre-breakfast glucose
3. If fasting BG remains >130 mg/dL: Increase by another 2 units to 22 units
4. Target: Fasting plasma glucose <130 mg/dL with <10% of readings <70 mg/dL 1
5. Once basal optimized: Reassess ICR by checking 2-4 hour post-meal glucose (should be within ±20% of pre-meal value)
6. If post-prandial excursions persist: Tighten ICR to 1:8 or 1:9

Key Clinical Pitfalls

• Overbasalization warning: If you find yourself increasing Lantus beyond 0.5 units/kg/day or if bedtime-to-morning glucose differential becomes excessive, this signals need for adjunctive therapy rather than more basal insulin 1, 4
• Hypoglycemia protocol: If any glucose <70 mg/dL occurs, reduce the most recent dose adjustment by 10-20% 1, 2
• Timing matters: Ensure Lantus is given at the same time daily; variable timing affects the flat pharmacokinetic profile 2

The 2025 ADA Standards recommend titrating basal insulin by 2 units every 3 days using evidence-based algorithms, with dose reductions of 10-20% for unexplained hypoglycemia 1. The FDA label for Lantus emphasizes individualized dosing based on glucose monitoring, with adjustments made only under medical supervision 2.